These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 26121344

  • 1. Journal of Pediatric Gastroenterology and Nutrition. Introduction.
    Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S1. PubMed ID: 26121344
    [No Abstract] [Full Text] [Related]

  • 2. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [Abstract] [Full Text] [Related]

  • 3. Introduction.
    Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S1. PubMed ID: 26422092
    [No Abstract] [Full Text] [Related]

  • 4. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
    [Abstract] [Full Text] [Related]

  • 5. Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
    Gilger MA, Tolia V, Vandenplas Y, Youssef NN, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S16-23. PubMed ID: 26121345
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
    Omari T, Davidson G, Bondarov P, Nauclér E, Nilsson C, Lundborg P.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S2-8. PubMed ID: 26121346
    [Abstract] [Full Text] [Related]

  • 7. In brief: Esomeprazole strontium.
    Med Lett Drugs Ther; 2014 Jul 21; 56(1447):64. PubMed ID: 25046421
    [No Abstract] [Full Text] [Related]

  • 8. Esomeprazole for the Treatment of GERD in Infants Ages 1-11 Months.
    Winter H, Gunasekaran T, Tolia V, Gottrand F, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul 21; 60 Suppl 1():S9-15. PubMed ID: 26121349
    [Abstract] [Full Text] [Related]

  • 9. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
    Castellani C, Singer G, Kashofer K, Huber-Zeyringer A, Flucher C, Kaiser M, Till H.
    Front Cell Infect Microbiol; 2017 Jul 21; 7():444. PubMed ID: 29075620
    [Abstract] [Full Text] [Related]

  • 10. Comment to "predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease".
    Savarino E, Giacchino M, Brunacci M, Savarino V.
    Dig Liver Dis; 2013 Oct 21; 45(10):868-9. PubMed ID: 23583546
    [No Abstract] [Full Text] [Related]

  • 11. Author's reply to "comment on: predictors of clinical response of acid suppression in Chinese patients with gastrooesophageal reflux disease".
    Wang AJ, Wang H, Zhu X.
    Dig Liver Dis; 2013 Oct 21; 45(10):869-70. PubMed ID: 23664269
    [No Abstract] [Full Text] [Related]

  • 12. Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response.
    Earp JC, Mehrotra N, Peters KE, Fiorentino RP, Griebel D, Lee SC, Mulberg A, Röhss K, Sandström M, Taylor A, Tornøe CW, Wynn EL, Van der Walt JS, Garnett C.
    J Pediatr Gastroenterol Nutr; 2017 Sep 21; 65(3):272-277. PubMed ID: 27875488
    [Abstract] [Full Text] [Related]

  • 13. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
    Jonasson C, Tvete IF, Hatlebakk JG.
    Scand J Gastroenterol; 2013 Sep 21; 48(9):1010-7. PubMed ID: 23859491
    [Abstract] [Full Text] [Related]

  • 14. Esomeprazole: in gastroesophageal reflux disease in children and adolescents.
    Croxtall JD, Perry CM, Keating GM.
    Paediatr Drugs; 2008 Sep 21; 10(3):199-205. PubMed ID: 18454572
    [No Abstract] [Full Text] [Related]

  • 15. Sticky Palms Following Use of Proton-Pump Inhibitors.
    Alkeraye S, Baclet Y, Delaporte E.
    JAMA Dermatol; 2016 Jun 01; 152(6):722-3. PubMed ID: 26962767
    [No Abstract] [Full Text] [Related]

  • 16. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
    Franke A, Hepp C, Harder H, Beglinger C, Singer MV.
    Scand J Gastroenterol; 2008 Jun 01; 43(12):1425-31. PubMed ID: 18924018
    [Abstract] [Full Text] [Related]

  • 17. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA, Pallentino J, Miller SK, VanBeuge SS.
    J Am Acad Nurse Pract; 2010 Dec 01; 22(12):674-83. PubMed ID: 21129076
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G, Wenzl TG, Thomson M, Omari T, Barker P, Lundborg P, Illueca M.
    J Pediatr; 2013 Sep 01; 163(3):692-8.e1-2. PubMed ID: 23800403
    [Abstract] [Full Text] [Related]

  • 19. FDA approves nexium for use in children ages 1-11 years.
    Lang L.
    Gastroenterology; 2008 May 01; 134(5):1282. PubMed ID: 18471499
    [No Abstract] [Full Text] [Related]

  • 20. [Lupus erythematosus and proto-pump inhibitors].
    Schmutz JL, Trechot P.
    Ann Dermatol Venereol; 2014 Mar 01; 141(3):252-3. PubMed ID: 24635967
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.